Tokyo, Nov. 13 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063577) titled 'Real-world clinical data of geographic atrophy with or without treatments with avacincaptad pegol in Japan' on Nov. 13.
Study Type:
Observational
Primary Sponsor:
Institute - Fujita Medical Innovation Center, Tokyo
Condition:
Condition - age-related macular degeneration with geographic atrophy
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - We analyze clinical courses of the patients diagnosed with age-related macular degeneration with geographic atrophy with or without izervay treatment and show the safety and efficacy of the treatment.
Basic objectives2 - Safety...